Premium
Mammalian target of rapamycin ( mTOR )‐related non‐infectious pneumonitis: a potential biomarker of clinical benefit?
Author(s) -
RodriguezVida Alejo,
Chau NoanMinh,
Chowdhury Simon
Publication year - 2014
Publication title -
bju international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 1464-4096
DOI - 10.1111/bju.12493
Subject(s) - temsirolimus , medicine , biomarker , pi3k/akt/mtor pathway , clinical trial , oncology , discovery and development of mtor inhibitors , pneumonitis , sirolimus , lung , biology , signal transduction , biochemistry